ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2025
Combined Use of Aqueous Extracts and Polysaccharides from Angelica sinensis and Platycladus orientalis Treats Androgenetic Alopecia.
Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Androgenetic alopecia (AGA) is a widely prevalent condition that significantly impacts both physical well-being and psychological health. Conventional treatments are often accompanied by considerable side effects and demonstrate variable efficacy. This study explores the therapeutic potential of polysaccharides derived from Angelica sinensis (ASP) and Platycladus orientalis (POP), alongside their respective aqueous extracts, employing a dual approach that combines oral administration of polysaccharides with topical application. Notably, these polysaccharides and their aqueous extracts effectively attenuate follicular miniaturization and chronic inflammation, while simultaneously promoting the expression of CD31 and Ki67 proteins, thereby enhancing angiogenesis and follicular development. Furthermore, they reactivate the Wnt/β-catenin signaling pathway and inhibit androgen receptors (AR), resulting in a significant stimulation of hair regrowth. Cumulatively, the polysaccharides and their aqueous extracts indicate a promising approach for mitigating hair loss and inflammation linked to AGA, offering preliminary evidence for a novel therapeutic intervention in AGA that warrants further investigation.
Indexed as
Identifiers
41247552What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.